AI_MODEL_CONFIDENCE_CALIBRATION.md

Model Confidence Calibration & Reliability Governance

1. Purpose

This document defines the confidence calibration requirements for all AI models operating within the NeuroGrid ecosystem.

Its objective is to ensure that:

Model confidence scores accurately reflect real-world performance

Clinical users are not misled by over- or under-confidence

AI outputs remain interpretable, safe, and regulator-aligned

Advisory AI behavior remains within validated reliability bounds

Confidence calibration is a clinical safety control, not a statistical optimization exercise.

2. Scope

This policy applies to:

All AI models producing probabilistic, categorical, or risk-scored outputs

Remote Patient Monitoring (RPM) inference systems

Clinical decision support models

Any downstream system that exposes confidence, likelihood, or certainty indicators

It covers both pre-deployment and post-deployment calibration obligations.

3. Calibration Principle

A confident model must be correct at the rate it claims.

If a model outputs a 90% confidence score, it must be correct approximately 90% of the time within its validated domain.

Deviation beyond defined tolerances constitutes a safety signal.

4. Calibration Objectives

Calibration processes must ensure:

Alignment between predicted confidence and empirical accuracy

Stability across populations and data distributions

Resistance to drift-induced overconfidence

Transparency to clinicians and auditors

Calibration must prioritize clinical reliability over raw performance metrics.

5. Calibration Methods (Approved)

Permitted calibration techniques include:

Platt Scaling

Isotonic Regression

Temperature Scaling

Bayesian uncertainty estimation

Ensemble disagreement analysis

Unapproved or experimental methods may be used only in sandboxed evaluation environments.

6. Validation Requirements

Before deployment, calibration must be validated against:

Independent validation datasets

Clinically representative cohorts

Edge-case and minority subpopulations

Validation artifacts must include:

Calibration curves

Expected Calibration Error (ECE)

Brier scores

Confidence–accuracy alignment tables

7. Confidence Threshold Classes

Model confidence outputs are categorized into classes:

Confidence Range	Interpretation	System Action
≥ 0.90	High confidence	Advisory output permitted
0.70 – 0.89	Moderate confidence	Advisory with caution flag
0.50 – 0.69	Low confidence	Escalation recommended
< 0.50	Unreliable	Output suppressed

Thresholds are model-specific but must be explicitly documented.

8. Clinical Presentation Rules

Confidence indicators presented to clinicians must:

Avoid misleading precision

Use qualitative descriptors alongside numeric values

Clearly communicate uncertainty

Never imply diagnostic certainty

No confidence value may be displayed without contextual explanation.

9. Post-Deployment Monitoring

Calibration must be continuously monitored for:

Population drift

Data source changes

Performance degradation

Confidence inflation or collapse

Recalibration triggers include:

Sustained ECE deviation

Increased clinician override rates

Adverse event correlation

Registry-detected drift signals

10. Drift & Recalibration Protocol

When calibration drift is detected:

Model confidence outputs may be down-weighted

Warning banners may be activated

Recalibration is performed off-chain

Results undergo expert review

Updated calibration is re-registered

Emergency confidence suppression is permitted if patient safety is at risk.

11. Registry & Audit Requirements

All calibration states must be registered in the DeSci registry, including:

Calibration method used

Validation dataset reference

Effective confidence thresholds

Date of last recalibration

Historical calibration records are immutable and auditable.

12. Governance Controls

Calibration changes:

Require expert endorsement

May require DAO notification or approval depending on impact

Must not be influenced by token governance incentives

No governance vote may approve knowingly miscalibrated confidence outputs.

13. Prohibited Practices

The following are explicitly forbidden:

Inflating confidence to improve adoption

Suppressing uncertainty signals

Presenting confidence as diagnostic certainty

Removing low-confidence warnings without justification

Violations constitute a model safety breach.

14. Regulatory Alignment

This policy aligns with:

EU AI Act (Risk Management & Transparency)

FDA GMLP (Model reliability & monitoring)

ISO/IEC 23894 (AI risk management)

WHO guidance on AI uncertainty disclosure

Clinical decision support safety principles

15. Ethical Position

False certainty is more dangerous than acknowledged uncertainty.

Confidence calibration protects clinicians from misplaced trust and patients from silent harm.

Status

Active – Mandatory Safety Control
